Onset and Progression of Motor Deficits in Motor Neuron Degeneration (mnd) Mice Are Unaltered by the Glycine/NMDA Receptor Antagonist L-701,324 or the MAO-B Inhibitorr(−)-Deprenyl
- 31 January 1999
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 155 (1) , 49-58
- https://doi.org/10.1006/exnr.1998.6873
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- A placebo‐controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosisAnnals of Neurology, 1996
- Benefit of vitamin E, riluzole, and gababapentin in a transgenic model of familial amyotrophic lateral sclerosisAnnals of Neurology, 1996
- Effects of brain‐derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron diseaseAnnals of Neurology, 1995
- The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron diseaseAnnals of Neurology, 1994
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- Synaptosomal Glutamate Uptake Declines Progressively in the Spinal Cord of a Mutant Mouse with Motor Neuron DiseaseJournal of Neurochemistry, 1993
- A pilot trial of dextromethorphan in amyotrophic lateral sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- Increased binding of3H-L-deprenyI in spinal cords from patients with amyotrophic lateral sclerosis as demonstrated by autoradiographyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
- Histopathology of the late-onset motor neuron degeneration (Mnd) mutant in the mouseJournal of Neurogenetics, 1987
- An hereditary motor neurone disease with progressive denervation of muscle in the mouse: the mutant 'wobbler'.Journal of Neurology, Neurosurgery & Psychiatry, 1968